About Ricerca Biosciences
Founded in 1986, Ricerca Biosciences offers a comprehensive suite of discovery, preclinical and development services to support drug candidates from lead identification through IND and NDA on a global scale. Capabilities include molecular through in vivo screening and profiling, as well as radiochemistry, IND-enabling toxicology, API process chemistry and cGMP manufacturing of clinical and commercial API. Our experienced scientists deliver world-class expertise and services to help you shorten time to IND and bring molecules to the clinic faster.
In addition to U.S.-based facilities in Concord, Ohio, and Bothell, Washington, Ricerca also has ISO 9001-certified facilities in Taipei, Taiwan, and Lyon, France. The Lyon facility also holds certification from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Discovery Pharmacology
- Molecular profiling & screening
- Functional pharmacology
- Early cellular toxicology
- Cellular oncology and immune systems
- In vivo safety and disease models
- Discovery DMPK
Chemical Development
- Analytical chemistry
- Process chemistry
- Engineering and scale-up
- Radiosynthesis
- API production with cGMP controls
Drug Safety and Metabolism
- General toxicology
- Safety pharmacology
- Continuous infusion
- Juvenile toxicology
- DART
- Bioanalytical services